These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 6362585)
21. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate. Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661 [TBL] [Abstract][Full Text] [Related]
22. Fibronectin in severe sepsis. Stevens LE; Clemmer TP; Laub RM; Miya F; Robbins L Surg Gynecol Obstet; 1986 Mar; 162(3):222-8. PubMed ID: 3082023 [TBL] [Abstract][Full Text] [Related]
23. Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis. Lanser ME; Saba TM; Scovill WA Ann Surg; 1980 Dec; 192(6):776-82. PubMed ID: 7447531 [TBL] [Abstract][Full Text] [Related]
24. Immunoreactive serum opsonic alpha 2 sb glycoprotein as a noninvasive index of RES systemic defense after trauma. Kaplan JE; Saba TM Adv Shock Res; 1979; 2():83-92. PubMed ID: 262806 [TBL] [Abstract][Full Text] [Related]
25. Opsonic fibronectin is necessary for optimal serum-mediated phagocytosis of Staphylococcus aureus by human neutrophils. Lanser ME; Saba TM Adv Shock Res; 1982; 8():111-7. PubMed ID: 7136937 [TBL] [Abstract][Full Text] [Related]
26. Neutrophil chemiluminescence and opsonic fibronectin levels following blunt trauma. Lanser ME; Mao P; Brown GE; Mora R; Siegel JH J Surg Res; 1986 Sep; 41(3):264-73. PubMed ID: 3762132 [TBL] [Abstract][Full Text] [Related]
27. Amplification of the opsonic activity of fibronectin by a plasma factor lacking gelatin affinity. Blumenstock FA; Saba TM; Cardarelli PM; Cho E J Reticuloendothel Soc; 1983 Jan; 33(1):21-33. PubMed ID: 6834358 [TBL] [Abstract][Full Text] [Related]
28. Plasma fibronectin time course in burned patients: influence of sepsis. Ekindjian OG; Marien M; Wassermann D; Bruxelle J; Cazalet C; Konter E; Yonger J J Trauma; 1984 Mar; 24(3):214-9. PubMed ID: 6708140 [TBL] [Abstract][Full Text] [Related]
29. Fibronectin and the critically ill patient: current status. Saba TM; Kiener JL; Holman JM Intensive Care Med; 1986; 12(5):350-8. PubMed ID: 3534039 [TBL] [Abstract][Full Text] [Related]
30. The role of plasma fibronectin as a nonantibody, noncomplement opsonin for Staphylococcus aureus. Deitch EA; Gelder F; McDonald JC J Trauma; 1984 Mar; 24(3):208-13. PubMed ID: 6708139 [TBL] [Abstract][Full Text] [Related]
31. Suppressive effect of ulinastatin on plasma fibronectin depression after cardiac surgery. Haniuda M; Morimoto M; Sugenoya A; Iida F Ann Thorac Surg; 1988 Feb; 45(2):171-3. PubMed ID: 3341822 [TBL] [Abstract][Full Text] [Related]
32. Failure of fibronectin as an opsonin in the host defence system: a case of competitive self inhibition? Brown RA Lancet; 1983 Nov; 2(8358):1058-60. PubMed ID: 6138603 [TBL] [Abstract][Full Text] [Related]
33. A new assay for fibronectin opsonic activity and its application to plasma and plasma fractions. Chang MD; Chin S; Horowitz B Vox Sang; 1985; 48(4):217-28. PubMed ID: 3984307 [TBL] [Abstract][Full Text] [Related]
34. [Dynamics of the plasma fibronectin level in patients with food poisoning]. Pak SG; Bogin IB; Kakhnovskaia NL; Sokurenko EV; Berchenko VV Ter Arkh; 1988; 60(11):71-5. PubMed ID: 3238583 [TBL] [Abstract][Full Text] [Related]
36. Plasma fibronectin concentrations in blood products. Perttilä J; Salo M; Peltola O Intensive Care Med; 1990; 16(1):41-3. PubMed ID: 2107234 [TBL] [Abstract][Full Text] [Related]
37. Fibronectin replacement in patients with fulminant hepatic failure. Hughes RD; Imawari M; Bihari D; Almasio PL; Langley PG; Williams R Eur J Clin Invest; 1986 Oct; 16(5):352-6. PubMed ID: 3100301 [TBL] [Abstract][Full Text] [Related]
38. Decreased plasma fibronectin during starvation in man. Howard L; Dillon B; Saba TM; Hofmann S; Cho E JPEN J Parenter Enteral Nutr; 1984; 8(3):237-44. PubMed ID: 6429359 [TBL] [Abstract][Full Text] [Related]
39. Plasma fibronectin levels during cardiopulmonary bypass. Charash WE; Foster ED; Saba TM; Dayton C; Cho E J Appl Physiol (1985); 1990 Nov; 69(5):1644-50. PubMed ID: 2272956 [TBL] [Abstract][Full Text] [Related]